Context Therapeutics to Showcase Cancer Immunotherapy Advances at Investor Events
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced it will present at two upcoming investor conferences in November, highlighting its growing pipeline of T cell–engaging bispecific antibodies for solid …
Context Therapeutics to Showcase Cancer Immunotherapy Advances at Investor Events Read More